Procter & Gamble Acquires Thorne in Strategic Health Brand Deal

Thorne, a leader in science-backed health and wellness solutions, has entered into a definitive agreement to be acquired by Procter & Gamble (P&G). The acquisition is expected to close later this year, subject to customary closing conditions and regulatory approvals.

The deal positions Thorne to continue advancing its mission of becoming the world's most trusted personalized health brand. Thorne has been a trusted partner to healthcare practitioners for over 40 years, serving consumers, athletes, and healthcare professionals through rigorous science, quality manufacturing, and uncompromising standards.

Thorne CEO Colin Watts said that P&G is the right partner to help the company expand its impact while staying true to its values and standards. Paul Gama, CEO of P&G Health Care, stated that Thorne strengthens their position in premium wellness with a trusted, science-backed brand that complements their existing portfolio.